Melanoma Clinical Trials

A listing of Melanoma medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 261 clinical trials
The Effect of Diet and Exercise on ImmuNotherapy and the Microbiome (EDEN)

see if nutritional intake and physical activity change the gut microbiome in people with melanoma. Eligibility Adults age 18 and older with previously untreated

nivolumab
cancer
measurable disease
systemic therapy
unresectable melanoma
  • 0 views
  • 12 May, 2022
  • 1 location
Testing the Addition of the Anti-cancer Drug, Tazemetostat, to the Usual Treatment (Dabrafenib and Trametinib) for Metastatic Melanoma That Has Progressed on the Usual Treatment

This phase I/II trial investigates the best dose, possible benefits and/or side effects of tazemetostat in combination with dabrafenib and trametinib in treating patients with melanoma that has

  • 0 views
  • 12 May, 2022
  • 3 locations
Immunotherapy With IFx-Hu2.0 Vaccine for Advanced Non-melanoma Skin Cancers

In this clinical phase I, non-randomized, open-label, uncontrolled, interventional, multi-center trial, 20 adult subjects (≥ 18 years of age) with advanced non-melanoma skin cancers will receive

serum aspartate aminotransferase
platelet count
squamous cell carcinoma
hysterectomy
measurable disease
  • 2 views
  • 21 Apr, 2022
  • 4 locations
Nab-Paclitaxel and Bevacizumab in Treating Patients With Unresectable Stage IV Melanoma or Gynecological Cancers

This phase I trial studies the side effects and best dose of nab-paclitaxel and bevacizumab in treating patients with stage IV melanoma that cannot be removed by surgery (unresectable), cancer

MRI
cancer antigen 125
platelet count
pet/ct scan
cervical carcinoma
  • 7 views
  • 04 May, 2022
  • 4 locations
Isolated Hepatic Perfusion in Combination With Ipilimumab and Nivolumab in Patients With Uveal Melanoma Metastases (SCANDIUM II)

immunotherapy in the treatment arsenal for cutaneous melanoma also creates hope for patients with uveal melanoma metastases. However, the results of immunotherapy have so far been disappointing. The reason for

  • 0 views
  • 11 May, 2022
  • 1 location
Intratumoral Injection of LTX-315 in Combination With Pembrolizumab in Advanced Melanoma (ATLAS-IT-05)

ATLAS-IT-05 is an open-label, single-arm study in patients with advanced melanoma accessible for injections (cutaneous, subcutaneous, lymph node, or intramuscular tumors) and who have either

  • 0 views
  • 18 May, 2022
  • 2 locations
Phase II Trial of Combination Anti-PD-1 and Aldesleukin for Metastatic Melanoma and Renal Cell Carcinoma

Background Aldesleukin is used to treat metastatic or advanced melanoma and renal cell carcinoma. Pembrolizumab is used to treat many cancers including melanoma

  • 0 views
  • 13 May, 2022
  • 1 location
PHP and Immunotherapy in Metastasized UM (CHOPIN)

Melanoma of the eye (ocular/uveal melanoma) is an uncommon type of cancer that is associated with a high mortality. It usually disseminates rapidly throughout the body, most commonly to the

  • 1 views
  • 23 Apr, 2022
  • 1 location
Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer Patients

advanced malignancies in separate tumor cohorts. The two cancers types are NSCLC and melanoma that are progressing on CPI treatment.

endometrial adenocarcinoma
ipilimumab
cancer
monoclonal antibodies
metastasis
  • 2 views
  • 09 May, 2022
  • 9 locations
Talimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or Advanced or Refractory Non-melanoma Skin Cancers

This phase II trial studies how well talimogene laherparepvec and nivolumab work in treating patients with lymphomas that do not responded to treatment (refractory) or non-melanoma skin cancers

sezary syndrome
signet ring cell carcinoma
squamous cell carcinoma
monoclonal antibodies
mycosis
  • 511 views
  • 09 May, 2022
  • 6 locations